Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

PPIs match surgery in gastroesophageal reflux

Proton pump inhibitors are as effective as surgery in managing gastroesophageal reflux disease, shows the latest report from the US Agency for Healthcare Research and Quality.

News image

fiogf49gjkf04

The US Agency for Healthcare Research and Quality reports treatments for chronic uncomplicated gastroesophageal reflux disease.

The report reviews the effectiveness of medical treatments used by Medicare, Medicaid, and the State Children's Health Insurance Program.

The review was developed by the Tufts New England Medical Center in Boston, Massachusetts.

This review is the first to compares treatment by reviewing existing studies and comparing the outcomes.

The reviewers defined gastroesophageal reflux disease as heartburn or acid regurgitation at least once a week.

The report analyzed randomized and non-randomized comparative studies, recent meta-analyses and cohort studies.

PPIs relieved symptoms of reflux disease as effectively as fundoplication surgery
US Agency for Healthcare Research and Quality

The studies assessed the use of over the counter drugs, proton pump inhibitors (PPIs), fundoplication surgery, and endoscopic procedures.

The report showed that proton pump inhibitors were as effective as fundoplication surgery in relieving the symptoms of reflux disease.

Proton pump inhibitors were also as effective as fundoplication surgery in reducing exposure to esophageal acid, and improving patients' quality of life.

Only a few studies had directly compared these approaches, however, and the total number of patients studied was small.

The review found significant differences in clinical effectiveness between different proton pump inhibitors.

However, the differences noted were modest and the report found the clinical implications unclear.

The evidence showed that the drugs and surgery had similar long term effects in preventing the development of Barrett's esophagus or esophageal adenocarcinoma.

The review found that over the counter H2 receptor antagonist drugs were less effective than proton pump inhibitors.

Over the counter H2 receptor antagonists were, however, associated with fewer side effects, including headache, diarrhoea, and abdominal pain.

The report also noted that surgery was sometimes used to reduce the need for patients to take drugs.

The report showed that 10% to 65% of patients had to resume their use of drugs after having had surgery.

Carolyn Clancy, director of the agency, commented, “This report takes a new step by asking not merely which treatments can be effective, but how treatments compare with one another.”

“It will provide a useful balanced source for obtaining the best scientific information to help select the right treatment for the patient.”

“However, reviews do not constitute treatment recommendations and do not include cost considerations.”

“Randomized controlled trials with long term follow-up comparing laparoscopic fundoplication with proton pump inhibitors to assess the relative benefits and harms of each approach are needed.”

“More efficacy and safety data are also needed with new endoscopic approaches tested against sham procedures.”

AHRQ 2005: 13 December, Effective Health Care Report
12 January 2006

Go to top of page Email this page Email this page to a colleague

 24 May 2018 
Precision medicine for tumors
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 23 May 2018 
High body mass index is and ulcerative colitis
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Fecal incontinence and quality of life in IBD
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us